Regions Financial Corp’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,785
Closed -$294K 841
2024
Q1
$294K Buy
6,785
+2,700
+66% +$117K ﹤0.01% 716
2023
Q4
$207K Buy
+4,085
New +$207K ﹤0.01% 786
2023
Q3
Sell
-5,110
Closed -$210K 820
2023
Q2
$210K Buy
+5,110
New +$210K ﹤0.01% 779
2023
Q1
Sell
-5,346
Closed -$202K 843
2022
Q4
$202K Hold
5,346
﹤0.01% 788
2022
Q3
$236K Buy
+5,346
New +$236K ﹤0.01% 730
2022
Q2
Sell
-9,323
Closed -$345K 880
2022
Q1
$345K Hold
9,323
﹤0.01% 716
2021
Q4
$284K Sell
9,323
-100
-1% -$3.05K ﹤0.01% 791
2021
Q3
$316K Hold
9,423
﹤0.01% 742
2021
Q2
$376K Buy
+9,423
New +$376K ﹤0.01% 683
2021
Q1
Sell
-4,421
Closed -$250K 870
2020
Q4
$250K Sell
4,421
-120
-3% -$6.79K ﹤0.01% 732
2020
Q3
$215K Hold
4,541
﹤0.01% 725
2020
Q2
$268K Sell
4,541
-26
-0.6% -$1.53K ﹤0.01% 668
2020
Q1
$216K Hold
4,567
﹤0.01% 694
2019
Q4
$276K Hold
4,567
﹤0.01% 696
2019
Q3
$274K Buy
4,567
+146
+3% +$8.76K ﹤0.01% 674
2019
Q2
$284K Buy
4,421
+49
+1% +$3.15K ﹤0.01% 671
2019
Q1
$354K Hold
4,372
﹤0.01% 613
2018
Q4
$236K Hold
4,372
﹤0.01% 714
2018
Q3
$226K Hold
4,372
﹤0.01% 799
2018
Q2
$182K Sell
4,372
-61
-1% -$2.54K ﹤0.01% 851
2018
Q1
$196K Hold
4,433
﹤0.01% 836
2017
Q4
$223K Hold
4,433
﹤0.01% 809
2017
Q3
$225K Buy
4,433
+112
+3% +$5.69K ﹤0.01% 813
2017
Q2
$220K Buy
+4,321
New +$220K ﹤0.01% 827
2017
Q1
Sell
-5,321
Closed -$255K 888
2016
Q4
$255K Buy
+5,321
New +$255K ﹤0.01% 791
2016
Q2
Sell
-5,096
Closed -$206K 880
2016
Q1
$206K Sell
5,096
-364
-7% -$14.7K ﹤0.01% 830
2015
Q4
$338K Sell
5,460
-80
-1% -$4.95K ﹤0.01% 709
2015
Q3
$224K Sell
5,540
-27
-0.5% -$1.09K ﹤0.01% 843
2015
Q2
$320K Sell
5,567
-15
-0.3% -$862 ﹤0.01% 754
2015
Q1
$356K Buy
5,582
+542
+11% +$34.6K ﹤0.01% 717
2014
Q4
$311K Sell
5,040
-8,649
-63% -$534K ﹤0.01% 757
2014
Q3
$531K Sell
13,689
-914
-6% -$35.5K 0.01% 757
2014
Q2
$503K Buy
14,603
+8,686
+147% +$299K 0.01% 797
2014
Q1
$255K Buy
5,917
+877
+17% +$37.8K ﹤0.01% 982
2013
Q4
$201K Buy
+5,040
New +$201K ﹤0.01% 1071